Find Drug Substances that produce:
Small Molecule APIs
Filters
Production region
Production scale
Qualifications
Follow us
CDMO-CRO
Plants in:
Established in: 1886
Production scale:
medium
small
Employees: 275+
Raw materials, CMO and OTC products
Two GMP certified locations
Customisable (small-sized) packages
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2023
Production scale:
small
medium
large
Employees: 1000+
Expertise in Conventional, Complex, and Niche Chemistries
End-to-end Support from early development to Commercial Phases
Comprehensive Analytical Support Facilities
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2008
Production scale:
large
small
medium
Employees: 4.000
With 14 production sites in Europe and the USA
7 Development Centers of Excellence covering all dosage forms
13 locations with Technology Services on site for seamless Tech Transfer and product Life-Cycle Management
All certificates
Replies quickly
Plants in:
Established in: 1982
Production scale:
small
Employees: 30+
Modern GMP facility
Team of academics and technical experts
Small to large batch sizes possible
All certificates
Replies quickly
Certified by US FDA
Well-Established Environmental, Health & Safety Protocols
Seasoned Project Execution Team
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1972
Production scale:
medium
Employees: 1,000+
EU-GMP for APIs and CEP for certain APIs
Exporting to over 50 countries worldwide
Long-standing technological advantage in adamantane, quinuclidine and nitrofurane chemistry
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1989
Production scale:
large
Employees: 5000+
6 production facilities approved by USFDA, AGES-Austria, PMDA, WHO
R&D Centers with capabilities of ANDAs, DMFs and NDDS
462+ patents filed for drug substances and polymorphs
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1987
Production scale:
medium
small
large
Employees: 50+
ISO 9001:2015 & SGS audited supplier
One-stop CDMO Solutions for APl and Key intermediates
Specialized in APIs & Pharmaceutical Intermediates for 38 years
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1952
Production scale:
small
medium
large
Employees: 550+
API manufacturing (Innovators, Generics and Highly Potent)
A tailor-made and flexible service approach
State-of-the-art analytical services including solid form and QbD laboratories
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2013
Production scale:
medium
Employees: 25+
ISO9001 certified
Drug R&D center (in Hangzhou)
From lab scale (mg/g) to commercial scale (kgs/tons)
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1991
Production scale:
small
medium
large
Employees: 3,500+
More than 12 GMP manufacturing facilities (EU, US, India)
Portfolio of more than 240 commercial APIs
We are experts in the cGMP production of highly potent compounds
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1951
Production scale:
medium
Employees: 455+
Largest Polish manufacturer of pharmaceuticals and a leader of the Polish pharmaceutical market.
FDA approved european manufcaturing facilities
Export APIs to more than 60 countries worldwide
All certificates
Replies quickly
Plants in:
Established in: 2008
Production scale:
large
medium
Employees: 300+
More than 150 patents based on independent intelligence
Expertise in anti-tumor, anti-diabetes and cardiovascular API and intermediates.
GMP facility with annual production capacity of 300M
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2019
Production scale:
large
Employees: 10+
Focused on pharmaceutical industry
Reasonable price for the customers
Full service from R&D stage to commercial stage
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 2021
Production scale:
small
Employees: 19
API, Intermediates, Building Blocks, Impurities, Amino acids and Peptides
Small quantity APIs to commercial scale
GMP and USFDA certification based on quantity, order, assignment.
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1980
Production scale:
medium
Employees: 30+
EU-GMP and DIN EN ISO 9001:2015
Pioneer in the fractionation of sheep plasma
Pure & sterile high-quality products
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1993
Production scale:
small
medium
large
Employees: 600
Integrated innovative platforms for Technology Transfer (TT&GO®)
Fermentation, purification, and chemical synthesis technologies on the same site
Scalability from Laboratory and Pilot to Industrial scales
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1965
Production scale:
small
medium
large
Employees: 600+
Pharmaceutical-quality dextrans meeting the highest standards and complying with major pharmacopeias
Manufactured in a cGMP facility in Denmark, inspected by both the FDA and EMA
Documented quality and certifications from the US FDA and EDQM for smooth regulatory submission
All certificates
Replies quickly
Plants in:
Established in: 2014
Production scale:
small
medium
large
Employees: 1000+
23 years of production experience
6 workshops and 9 production lines which has 100t/month production capacity
4 USDMFS & 5 CEPS & 200+ Patents
All certificates
Replies quickly
CDMO-CRO
Plants in:
Established in: 1964
Production scale:
small
medium
large
Employees: 135+
Market leader in Switzerland
Small and medium batch sizes
Pharmaceutical raw materials with a herbal or synthetic basis
All certificates
Replies quickly
CDMO-CRO
Specialized in liquid and semi-solid pharmaceuticals manufacturing.
Nordic excellence in quality and reliability.
Flexible production capabilities catering to a wide range of batch sizes.
All certificates
Replies slower than most
CDMO-CRO
Comprehensive drug development services from molecule to market.
Expertise in nanomedicine and drug repurposing.
Tailored project management ensuring efficiency and transparency.
All certificates
Replies slower than most
Looking for Drug Substance Services?
Find a list of providers specializing in CMOs/CDMOs Services for Small Molecule APIs. Navigate through our extensive selection to identify the supplier that aligns with your specific needs.
Pharmaoffer makes it easy and convenient to send inquiries at no cost. Directly connect with your chosen supplier and take the first step towards fulfilling your pharmaceutical needs easily and efficiently.
Drug Substance (CDMO/CRO)
Drug Substance CDMOs and CROs provide end-to-end solutions for pharmaceutical companies developing and manufacturing active pharmaceutical ingredients (APIs). These organizations offer critical support in R&D, process development, scale-up, and GMP manufacturing, enabling pharma and biotech companies to accelerate time-to-market while ensuring compliance with global regulatory standards.
Small Molecule APIs
Small molecule APIs are chemically synthesized compounds with low molecular weight, commonly used in pharmaceuticals. They offer predictable pharmacokinetics and are cost-effective to produce at scale.
